Across TCGA pan-cancer cohorts, ARPC1BP1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ARPC1BP1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ARPC1BP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARPC1BP1 is over-expressed in tumor.

HNSC, LUSC, and LIHC are the cancer types where ARPC1BP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARPC1BP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.137	.001	8	view →
LUSC	All	All	+0.181	<.001	5	view →
LIHC	All	All	+0.046	.003	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ARPC1BP1 RNA expression & survival · all ARPC1BP1 data types